Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd3f413aacd39c819d18e633c170041d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
filingDate |
2007-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1111ae108945cb2e0997073c15d1bbab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6a01ac6b5abbc49f0a2e2d10ce8ec9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f134b6a916c35603aed40daaa4d84eab |
publicationDate |
2009-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2019645-A2 |
titleOfInvention |
Delivery of ophthalmologic agents to the exterior or interior of the eye |
abstract |
The present invention provides intraocular polymer delivery compositions based on biodegradable polyester amide (PEA), polyester urethane (PEUR), and polyester urea (PEU) polymers, which contain amino acids. The compositions can be formulated as an implantable solid or as a liquid dispersion of polymer particles for sustained delivery of ophthalmologic agents dispersed therein or incorporated into the backbone of the polymers. Methods of delivering an ophthalmologic agent to the exterior or interior of the eye by implanting the composition in the eye of a subject are also included. |
priorityDate |
2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |